PHENIXFIN CORP (PFX) Fundamental Analysis & Valuation

NASDAQ:PFX • US71742W1036

Current stock price

41.5 USD
+0.42 (+1.02%)
Last:

This PFX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. PFX Profitability Analysis

1.1 Basic Checks

  • In the past year PFX has reported negative net income.
  • PFX had a negative operating cash flow in the past year.
  • Of the past 5 years PFX 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: PFX reported negative operating cash flow in multiple years.
PFX Yearly Net Income VS EBIT VS OCF VS FCFPFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • PFX's Return On Assets of -1.00% is on the low side compared to the rest of the industry. PFX is outperformed by 75.83% of its industry peers.
  • PFX has a Return On Equity of -1.98%. This is in the lower half of the industry: PFX underperforms 70.83% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.47%, PFX is doing worse than 64.58% of the companies in the same industry.
  • PFX had an Average Return On Invested Capital over the past 3 years of 1.60%. This is significantly below the industry average of 7.19%.
Industry RankSector Rank
ROA -1%
ROE -1.98%
ROIC 1.47%
ROA(3y)6.23%
ROA(5y)3.3%
ROE(3y)10.85%
ROE(5y)5.68%
ROIC(3y)1.6%
ROIC(5y)2.55%
PFX Yearly ROA, ROE, ROICPFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 21.95%, PFX is in line with its industry, outperforming 47.92% of the companies in the same industry.
  • PFX's Operating Margin has declined in the last couple of years.
  • PFX's Gross Margin of 60.45% is fine compared to the rest of the industry. PFX outperforms 67.92% of its industry peers.
  • In the last couple of years the Gross Margin of PFX has grown nicely.
Industry RankSector Rank
OM 21.95%
PM (TTM) N/A
GM 60.45%
OM growth 3Y-2.47%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.03%
GM growth 5Y129.57%
PFX Yearly Profit, Operating, Gross MarginsPFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. PFX Health Analysis

2.1 Basic Checks

  • PFX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PFX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, PFX has a worse debt to assets ratio.
PFX Yearly Shares OutstandingPFX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
PFX Yearly Total Debt VS Total AssetsPFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • PFX has an Altman-Z score of -2.02. This is a bad value and indicates that PFX is not financially healthy and even has some risk of bankruptcy.
  • PFX's Altman-Z score of -2.02 is on the low side compared to the rest of the industry. PFX is outperformed by 88.33% of its industry peers.
  • A Debt/Equity ratio of 0.94 indicates that PFX is somewhat dependend on debt financing.
  • PFX has a Debt to Equity ratio of 0.94. This is comparable to the rest of the industry: PFX outperforms 53.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF N/A
Altman-Z -2.02
ROIC/WACCN/A
WACCN/A
PFX Yearly LT Debt VS Equity VS FCFPFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • PFX has a Current Ratio of 1.38. This is a normal value and indicates that PFX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of PFX (1.38) is better than 63.33% of its industry peers.
  • A Quick Ratio of 1.38 indicates that PFX should not have too much problems paying its short term obligations.
  • PFX has a better Quick ratio (1.38) than 63.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38
PFX Yearly Current Assets VS Current LiabilitesPFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PFX Growth Analysis

3.1 Past

  • The earnings per share for PFX have decreased strongly by -116.81% in the last year.
  • The Revenue has grown by 13.36% in the past year. This is quite good.
  • PFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.28% yearly.
EPS 1Y (TTM)-116.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-295.08%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y17.68%
Revenue growth 5Y3.28%
Sales Q2Q%7.25%

3.2 Future

  • PFX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.97% yearly.
  • The Revenue is expected to decrease by -3.42% on average over the next years.
EPS Next Y-142.57%
EPS Next 2Y-1.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.89%
Revenue Next 2Y-3.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFX Yearly Revenue VS EstimatesPFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
PFX Yearly EPS VS EstimatesPFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20

More info and screens

Find the best growth stocksShow best growing peers

1

4. PFX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PFX. In the last year negative earnings were reported.
  • PFX is valuated rather expensively with a Price/Forward Earnings ratio of 19.36.
  • PFX's Price/Forward Earnings ratio is in line with the industry average.
  • PFX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 19.36
PFX Price Earnings VS Forward Price EarningsPFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFX Per share dataPFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.97%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PFX Dividend Analysis

5.1 Amount

  • No dividends for PFX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PFX Fundamentals: All Metrics, Ratios and Statistics

PHENIXFIN CORP

NASDAQ:PFX (4/10/2026, 8:00:01 PM)

41.5

+0.42 (+1.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners27.62%
Inst Owner Change0%
Ins Owners21.74%
Ins Owner Change3.35%
Market Cap83.00M
Revenue(TTM)25.71M
Net Income(TTM)-3.08M
Analysts45
Price TargetN/A
Short Float %0.04%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.44
Dividend Growth(5Y)N/A
DP-93.81%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.28%
Min EPS beat(2)-708.9%
Max EPS beat(2)737.46%
EPS beat(4)1
Avg EPS beat(4)-100.82%
Min EPS beat(4)-708.9%
Max EPS beat(4)737.46%
EPS beat(8)5
Avg EPS beat(8)27.09%
EPS beat(12)9
Avg EPS beat(12)123.88%
EPS beat(16)11
Avg EPS beat(16)43.93%
Revenue beat(2)2
Avg Revenue beat(2)14.8%
Min Revenue beat(2)12.71%
Max Revenue beat(2)16.88%
Revenue beat(4)3
Avg Revenue beat(4)5.57%
Min Revenue beat(4)-8.6%
Max Revenue beat(4)16.88%
Revenue beat(8)6
Avg Revenue beat(8)11.2%
Revenue beat(12)9
Avg Revenue beat(12)9.09%
Revenue beat(16)13
Avg Revenue beat(16)10.76%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-158.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.36
P/S 3.23
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)2.14
Fwd EY5.16%
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS12.85
BVpS77.91
TBVpS77.91
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1%
ROE -1.98%
ROCE 1.87%
ROIC 1.47%
ROICexc 1.49%
ROICexgc 1.49%
OM 21.95%
PM (TTM) N/A
GM 60.45%
FCFM N/A
ROA(3y)6.23%
ROA(5y)3.3%
ROE(3y)10.85%
ROE(5y)5.68%
ROIC(3y)1.6%
ROIC(5y)2.55%
ROICexc(3y)1.76%
ROICexc(5y)3.28%
ROICexgc(3y)1.76%
ROICexgc(5y)3.3%
ROCE(3y)2.03%
ROCE(5y)3.23%
ROICexgc growth 3Y-4.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.03%
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.03%
GM growth 5Y129.57%
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.62
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z -2.02
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-295.08%
EPS Next Y-142.57%
EPS Next 2Y-1.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.36%
Revenue growth 3Y17.68%
Revenue growth 5Y3.28%
Sales Q2Q%7.25%
Revenue Next Year-2.89%
Revenue Next 2Y-3.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.41%
EBIT growth 3Y14.77%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.16%
OCF growth 3YN/A
OCF growth 5YN/A

PHENIXFIN CORP / PFX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PHENIXFIN CORP (PFX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PFX.


What is the valuation status for PFX stock?

ChartMill assigns a valuation rating of 1 / 10 to PHENIXFIN CORP (PFX). This can be considered as Overvalued.


Can you provide the profitability details for PHENIXFIN CORP?

PHENIXFIN CORP (PFX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for PFX stock?

The Earnings per Share (EPS) of PHENIXFIN CORP (PFX) is expected to decline by -142.57% in the next year.